NCT07584356 A Study Comparing Shoulder Replacement Techniques For Patients With Shoulder Arthritis And An Intact Rotator Cuff
| NCT ID | NCT07584356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Shoulder Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2026-05-05 |
| Primary Completion | 2029-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2026-05-05 with a primary completion date of 2029-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if patients undergoing anatomic total shoulder arthroplasty (aTSA) will have improved patient reported outcome scores at 1 year compared to those undergoing reverse total shoulder arthroplasty (rTSA).
Eligibility Criteria
Inclusion Criteria * Shoulder arthritis * Intact rotator cuff * Glenoid retroversion less than 25° Exclusion Criteria * Rotator cuff insufficiency * Fracture deformity/sequelae * Severe glenoid deformity (C glenoid, severe A2, B2 glenoid) * Current or previous infection of shoulder * Previous acromion fracture (not os acromiale) * Brachial plexopathy * Axillary neuropathy * Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements. * Inability or unwillingness of individual or legal guardian/representative to give written informed consent. * Medical conditions that would make 2 years follow up unlikely * Non-English speaking
Contact & Investigator
Jonathan D. Barlow, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07584356 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 85 Years, studying Shoulder Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07584356 currently recruiting?
Yes, NCT07584356 is actively recruiting participants. Contact the research team at anderson.luci@mayo.edu for enrollment information.
Where is the NCT07584356 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07584356 clinical trial?
NCT07584356 is sponsored by Mayo Clinic. The principal investigator is Jonathan D. Barlow, MD at Mayo Clinic. The trial plans to enroll 108 participants.